Non-coding RNAs and cancer: MicroRNAs and beyond

Journal of Nucleic Acids Investigation

Volumn 2, Issue 1, 2011, Pages 27-30

  Raia, Rachel ^a   Calin, George Adrian ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Hotair; Lincrna; Micrornas; Ucr

Indexed keywords

LARGE INTERVENING NON CODING RNA; MICRORNA; PROTEIN KINASE ZAP 70; RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; B CELL LEUKEMIA; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RESEARCH; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHRONIC LYMPHATIC LEUKEMIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CONSERVATION; HUMAN; METASTASIS; ONCOGENE; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 80052192126     PISSN: None     EISSN: 20356005     Source Type: Journal    
DOI: 10.4081/jnai.2011.e5     Document Type: Article

References (22)

1. Ambros, V. The functions of animal microRNAs. Nature 2004;431:350-5.
2. Calin GA, Croce CM. Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. Blood 2009;114:4761-70.
3. Leung AKL, Sharp PA. MicroRNA functions in stress responses. Molecular Cell 2010;40:205-15.
4. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.
5. Rossi S, Kopetz S, Davuluri R et al. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol 2010;42:1291-7.
6. Wojcik SE, Rossi S, Shimizu M, et al. Noncoding RNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis 2009;31:208-15.
7. Taby R, Issa JPJ. Cancer Epigenetics. CA Cancer J Clin 2010;60:376-92.
8. Fabbri M, Garzon R, Andreeff M, et al. MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 2008;22:1095-105.
9. Edwards JK, Pasqualini R, Arap W, Calin GA. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J Cardiovasc Transl Res 2010;3:271-9.
10. Van Kessel AG. Review of The 'omics' of cancer. Canc Genet Cytogenet 2010;203: 37-42.
11. Pelletier C, Weidhaas JB. MicroRNA binding site polymorphisms as biomarkers of cancer risk. Expert Rev Mol Diagn 2010;10:817-29.
12. Liang D, Meyer L, Chang DW, et al. Genetic variants in microRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res 2010;70:9765-76.
13. Rossi S, Sevignani C, Nnadi SC, et al. Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications. Mamm Genome 2008;19:526-40.
14. Scaruffi P, Stigliani S, Moretti S, et al. Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer. 2009;9:441.
15. Hausler SFM, Keller A, Chandran PA, et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 2010;103:693-700.
16. Wittman J, Jack HM. Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 2010;1806:200-7.
17. Fabbri M, Bottoni A, Shimizu M, et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011;305:59-67.
18. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009;9:703-711.
19. Nagpal JK, Rani R, Trink B, Saini KS. Targeting miRNAs for drug discovery: a new paradigm. Curr Mol Med 2010;10:503-10.
20. Taccioli C, Fabbri E, Visone R, et al. UCbase & miRfunc: a database of ultraconserved sequences and microRNA function. Nucleic Acids Res 2009;37:D41-8.
21. Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by non-coding RNAs. Cell 2007;129:1311-23.
22. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071-6.